Table 5.
Use of Lipid Lowering Drugs among Diabetic OSK With LDL-C >= 2.5 MMOL/L by Demographic Characteristics
| Persons with LDL-C ≥ 2.5 mmol/L† |
Persons dispensed a lipid lowering drug | Crude rate (%) | OR (95% CI) | |
|---|---|---|---|---|
| TOTAL | 6914 | 2711 | 39.2 | |
| AGE (years) Female | ||||
| 20-39 | 165 | 31 | 18.8 | 0.38 (0.26-0.58) |
| 40-49 | 389 | 123 | 31.6 | 0.77 (0.60-0.98) |
| 50-59 | 723 | 305 | 42.2 | 1.21 (1.00-1.46) |
| 60-69 | 795 | 329 | 41.4 | 1.17 (0.97-1.41) |
| ≥ 70* | 1157 | 435 | 37.6 | |
| AGE (years) Male | ||||
| 20-39 | 152 | 41 | 27.0 | 0.72 (0.50-1.06) |
| 40-49 | 428 | 174 | 40.7 | 1.34 (1.07-1.69) |
| 50-59 | 978 | 442 | 45.2 | 1.61 (1.35-1.93) |
| 60-69 | 1003 | 451 | 45.0 | 1.60 (1.34-1.91) |
| ≥ 70* | 1124 | 380 | 33.8 | |
| LOCATION | ||||
| urban* | 6196 | 2416 | 39.0 | |
| non-urban | 704 | 288 | 40.9 | 1.09 (0.9-1.3) |
| INCOME QUINTILE | ||||
| lowest | 1544 | 569 | 36.9 | 0.92 (0.79-1.08) |
| second | 1566 | 606 | 38.7 | 0.97 (0.83-1.13) |
| third | 1320 | 515 | 39.0 | 0.96 (0.82-1.13) |
| fourth | 1267 | 525 | 41.4 | 1.05 (0.90-1.24) |
| highest* | 1191 | 482 | 40.5 |
*Reference category
Drug prescribing data was not available for FN, hence, analysis for lipid lowering prescribing indicators was limited to OSK
Data are stratified by sex because age-sex interaction was present
† Sub-group of prevalent diabetes cases aged 20 years and older at beginning of fiscal year 2005/06 in Saskatchewan's two largest Health Regions